Evogene
EVGN
33 hedge funds and large institutions have $45M invested in Evogene in 2020 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 8 increasing their positions, 4 reducing their positions, and 4 closing their positions.
375% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 4
100% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 4
83% more funds holding
Funds holding: 18 → 33 (+15)
34% more capital invested
Capital invested by funds: $33.6M → $45M (+$11.3M)
0% more ownership
Funds ownership: 2.68% → 2.69% (+0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$911K |
| 2 |
PP
PDT Partners
New York
|
+$289K |
| 3 |
Jane Street
New York
|
+$258K |
| 4 |
Squarepoint
New York
|
+$236K |
| 5 |
JF
Jump Financial
Chicago,
Illinois
|
+$225K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Senvest Management
New York
|
-$504K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$360K |
| 3 |
PF
Phoenix Financial
Givatayim,
Israel
|
-$188K |
| 4 |
HIIFS
Harel Insurance Investments & Financial Services
Ramat Gan,
Israel
|
-$139K |
| 5 |
EVC
Eidelman Virant Capital
Saint Louis,
Missouri
|
-$136K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PWA
26
Phoenix Wealth Advisors
Chapel Hill,
North Carolina
| $29K | +$21.2K | +600 | New |
|
|
SPIA
27
Steward Partners Investment Advisory
New York
| $24K | – | – | – |
|
|
IA
28
IFP Advisors
Tampa,
Florida
| $24K | +$17.6K | +500 | New |
|
|
PFO
29
Pathstone Family Office
Englewood,
New Jersey
| $23K | +$17.3K | +491 | New |
|
|
GWM
30
Geneos Wealth Management
Englewood,
Colorado
| $11K | +$8.81K | +250 | New |
|
|
TRCT
31
Tower Research Capital (TRC)
New York
| $5K | +$1.73K | +49 | +75% |
|
32
Bank of America
Charlotte,
North Carolina
| $4K | +$3.21K | +91 | New |
|
33
Osaic Holdings
Scottsdale,
Arizona
| $2K | +$176 | +5 | +14% |
|
|
PF
34
Phoenix Financial
Givatayim,
Israel
| – | -$188K | -5,041 | Closed |
|
|
HIIFS
35
Harel Insurance Investments & Financial Services
Ramat Gan,
Israel
| – | -$139K | -3,500 | Closed |
|
36
Renaissance Technologies
New York
| – | -$101K | -2,540 | Closed |
|
|
MIH
37
Meitav Investment House
Bene-Beraq,
Israel
| – | -$77K | -1,947 | Closed |
|
EVGN Hedge Fund Activity: Q4 2020 in Review
33 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Evogene (EVGN) for Q4 2020, worth a combined $45M — up 34% from $33.6M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new EVGN positions and 4 closed out — a net gain of 15 holders — while 8 added to existing stakes and 4 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $911K. The largest seller was Senvest Management, cutting an estimated $504K.
- 33 institutional investors held Evogene (EVGN) as of Q4 2020, up from 18 in Q3 2020.
- Funds reported $45M of Evogene stock for Q4 2020, up 34% quarter-over-quarter.
- 19 funds opened new Evogene positions in Q4 2020 and 4 closed out, a net change of +15 holders.
- The largest Evogene buyer in Q4 2020 was Morgan Stanley, an estimated $911K added.
- The largest Evogene seller in Q4 2020 was Senvest Management, an estimated $504K sold.
Based on aggregated 13F filings for Q4 2020.